Your browser doesn't support javascript.
loading
The structure-guided discovery of osimertinib: the first U.S. FDA approved mutant selective inhibitor of EGFR T790M.
Butterworth, Sam; Cross, Darren A E; Finlay, M Raymond V; Ward, Richard A; Waring, Michael J.
Afiliação
  • Butterworth S; AstraZeneca , Darwin Building , 310 Cambridge Science Park , Milton Road , Cambridge , CB4 0WG , UK . Email: ray.finlay@astrazeneca.com ; Email: richard.a.ward@astrazeneca.com.
  • Cross DAE; AstraZeneca , Darwin Building , 310 Cambridge Science Park , Milton Road , Cambridge , CB4 0WG , UK . Email: ray.finlay@astrazeneca.com ; Email: richard.a.ward@astrazeneca.com.
  • Finlay MRV; AstraZeneca , Darwin Building , 310 Cambridge Science Park , Milton Road , Cambridge , CB4 0WG , UK . Email: ray.finlay@astrazeneca.com ; Email: richard.a.ward@astrazeneca.com.
  • Ward RA; AstraZeneca , Darwin Building , 310 Cambridge Science Park , Milton Road , Cambridge , CB4 0WG , UK . Email: ray.finlay@astrazeneca.com ; Email: richard.a.ward@astrazeneca.com.
  • Waring MJ; AstraZeneca , Darwin Building , 310 Cambridge Science Park , Milton Road , Cambridge , CB4 0WG , UK . Email: ray.finlay@astrazeneca.com ; Email: richard.a.ward@astrazeneca.com.
Medchemcomm ; 8(5): 820-822, 2017 May 01.
Article em En | MEDLINE | ID: mdl-30108799
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Medchemcomm Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Medchemcomm Ano de publicação: 2017 Tipo de documento: Article